Keynote Lecture Series


Understanding and Embracing the Multigenerational Workforce of Today
September 17, 2017 9:45am - 10:45am
Presented by Anne Walsh-Feeks, MS, PA(ASCP), FACHE, Administrative Director, Pathology & Laboratory Medicine, NYU Winthrop Hospital  

The workforce of today is uniquely challenging. Traditionalists, Boomers, GenX and Millennials are some of the labels placed on our employees. Anne Walsh-Feeks, MS, PA(ASCP), FACHE will discuss the generational differences as well as strategies to attract, engage and retain employees in the current environment. Communication styles unique to each group will be explored. Discussion will center on ways to create an environment where workers of all ages can collaborate and succeed. 


C.F.A. Culling Memorial Lecture: Precision Medicine and Next Generation Sequencing: Challenges and Opportunities
September 18, 2017  9:45am – 10:45am
Presented by Jane Gibson, PhD, Chair, Department of Clinical Sciences, Professor of Pathology, Director of Molecular Diagnostics, University of Central Florida College of Medicine

Sponsored by Polyscientific R&D Corp

The introduction of high-throughput next-generation sequencing (NGS) was a critical and transformative event for diagnostic genome sequencing for personalized healthcare and precision medicine.  The power of NGS to generate hundreds of millions to multigigabase levels of DNA sequence has significantly expanded the possibilities for patient care and research, while stretching our ability to process and store data.  We can anticipate that as this powerful genome testing technology becomes more integrated into standards of patient care across multiple specialties, the role of laboratory professionals will broaden, and the needs to process and incorporate massive amounts of data into patient healthcare records will continue to expand.  

Dr. Gibson is currently Professor of Pathology and Chair, Department of Clinical Sciences, and Director of Molecular Diagnostics at the University of Central Florida College of Medicine.  She is board certified by the American Board of Medical Genetics and Genomics (ABMGG), is a fellow of the American College of Medical Genetics (ACMG), and serves as a member of the American Board of Medical Genetics and Genomics Board of Directors. Dr. Gibson received her training at the University of Florida College of Medicine, and her practice includes molecular pathology and molecular genetics.  She has served as the Director of Molecular Genetics for M.D. Anderson Cancer Center Orlando, and later as the  Director of Molecular Genetics and Cytogenetics for AmeriPath, Inc. (A Division of  Quest Diagnostics).  She participates in a number of national-level professional activities including serving as Chair of the Association for Molecular Pathology (AMP) Publications and Communications Committee and member of the AMP Board of Directors. She is on the editorial board for the Journal of Molecular Diagnostics, and has authored a number of book chapters, articles and published abstracts in the fields of molecular pathology and genetics, and has been the principle investigator for numerous clinical trials.

Back to Top